-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Speculative Buy on Genelux, Lowers Price Target to $20

Benzinga·03/20/2026 15:45:28
Listen to the news
Benchmark analyst Bruce D. Jackson maintains Genelux (NASDAQ:GNLX) with a Speculative Buy and lowers the price target from $23 to $20.